EquityRoots
Pharmaceuticals
Healthcare · Pharmaceuticals · Long-term Compounder

Laurus Labs Limited

LAURUSLABS·1100.95·₹59.4K Cr·Listed 19 Dec 2016
Composite
11
Bottom quartile in Pharmaceuticals · Long-term Compounder
Rank12of 12
About LAURUSLABS
www.lauruslabs.com
Laurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally.
Healthcare
Company description
Founded
2005
Headquarters
Hyderabad, India
CEO / MD
Dr. Satyanarayana Chava M.Sc., Ph.D. · CEO & Whole Time Director
Major milestone
No record found in disclosures
What they do
Core products
medicinesactive pharmaceutical ingredients (APIs) in Indiainternationally
Target customers
Not explicitly disclosed
Global footprint
IndiaInternational
2 regions mentioned in disclosures
Shareholder breakup
Public
32.7%-0.8
Promoter
27.5%
FII
25.8%-0.7
DII
14.0%+1.5
As of Mar 2026292281 holders
Read full description

Laurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company offers Generics APIs and oral solid formulations for advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, anti-asthma, ophthalmology, oncology, gastroenterology, and hepatitis C therapeutic areas. It also provides biotechnology services used in the nutraceutical, dietary supplements, alternate food proteins, and cosmeceutical products. In addition, the company develops novel enzymatic solutions for industrial biotechnology, and animal origin free recombinant proteins and enzymes for biopharma; and offers business support services for pharmaceuticals field. Laurus Labs Limited was incorporated in 2005 and is based in Hyderabad, India.

Sourced from public company disclosures.
About
Laurus Labs Limited
IndustryPharmaceuticals & Biotechnology
SectorHealthcare
ClusterPharmaceuticals · Long-term Compounder
Market cap₹59.4K Cr
Listed19 Dec 2016
Price history9 years available
Fundamentals10 years available
Price history
LAURUSLABS · monthly close, 2016–2026
+1225%
31.7% CAGR · 9y
1,228.3+633.54 (+106.52%)1Y